Developments in 3D Echocardiography

Login or register to view PDF.
Abstract

3D echocardiography (3DE) will gain increasing acceptance as a routine clinical tool as the technology evolves due to advances in technology and computer processing power. Images obtained from 3DE provide more accurate assessment of complex cardiac anatomy and sophisticated functional mechanisms compared with conventional 2D echocardiography (2DE), and are comparable to those achieved with magnetic resonance imaging. Many of the limitations associated with the early iterations of 3DE prevented their widespread clinical application. However, recent significant improvements in transducer and post-processing software technologies have addressed many of these issues. Furthermore, the most recent advances in the ability to image the entire heart in realtime and fully automated quantification have poised 3DE to become more ubiquitous in clinical routine. Realtime 3DE (RT3DE) systems offer further improvements in the diagnostic and treatment planning capabilities of cardiac ultrasound. Innovations such as the ability to acquire non-stitched, realtime, full-volume 3D images of the heart in a single heart cycle promise to overcome some of the current limitations of current RT3DE systems, which acquire images over four to seven cardiac cycles, with the need for gating and the potential for stitch artefacts.

Disclosure
The author has no conflicts of interest to declare.
Correspondence
Jose Luis Zamorano, Director, Cardiovascular Institute, University Clinic San Carlos, Plaza de Cristo Rey, 28040 Madrid, Spain. E: jlzamorano@vodafone.es
Received date
10 November 2009
Accepted date
26 November 2009
Citation
US Cardiology - Volume 7 Issue 1;2010:7(1):18-23
Correspondence
Jose Luis Zamorano, Director, Cardiovascular Institute, University Clinic San Carlos, Plaza de Cristo Rey, 28040 Madrid, Spain. E: jlzamorano@vodafone.es

2D echocardiography (2DE) is a common diagnostic and treatment planning tool in clinical cardiology, especially for the assessment of left ventricular (LV) volume and function. However, traditional 2DE is severely limited by its dependence on geometrical assumptions, which can lead to inaccuracies in volume quantification.1 Because 3D echocardiographic (3DE) imaging eliminates geometrical assumptions and image plane positioning error, the technique offers the potential for more accurate assessment of complex cardiac anatomy and sophisticated functional mechanisms. Early attempts at 3DE using images produced by freehand reconstruction from multiple gated 2D images required spatial tracking of each image. These initial attempts at 3DE of LV volumes and mass and LV ejection fractions (LVEF) produced superior results to 2DE, comparable to those of nuclear magnetic resonance (NMR) imaging.2,3 Although 3DE has been around for nearly two decades, limitations in the early iterations of the technology prevented their widespread clinical application. While advances in transducer and post-processing software technologies have addressed many issues, it is the most recent advances in the ability to image the entire heart in realtime and fully automated quantification that have poised 3DE to become more ubiquitous in clinical routine. The introduction and increasing availability of realtime 3DE (RT3DE) has the potential to further improve the diagnostic and treatment planning capabilities of cardiac ultrasound. While cardiac magnetic resonance imaging (MRI) is the current gold standard, the imaging modality may require the injection of a contrast agent, is not suitable for patients with implanted cardiac devices and can be more costly.

The Evolution of 3D Echocardiography

The acquisition of the first 3D cardiac ultrasound images dates back to 1974.4 This was followed by the development of early 3DE techniques, whereby 3DE images were obtained by offline sequential reconstruction of 2D images.2,3,5 However, these methods had limitations related to acquisition and post-processing: the images obtained were often of a relatively poor spatial and temporal resolution, while the reconstruction of the 2D data sets to produce 3D images was time-consuming and only available offline. More recently, matrix-array transducers have been introduced. These transducers contain an array of piezoelectric elements that are capable of scanning pyramidal volumes rather than 2D thin slices.

The matrix-array transducers enable rapid and realtime acquisition of 3D images, without the need for time-consuming offline reconstruction. The initial matrix-array transducers had a sparse array of elements that could obtain a 60ºx60º pyramidal volume of data, allowing realtime 3D image acquisition.6,7 Limitations associated with the earlier transducers included relatively poor image quality, low frame rates and narrow sector volume acquisition.
The next generation of transducers evolved to fully sampled array or provided significant improvements in the quality of the images. A fully sampled matrix-array transducer consists of thousands of simultaneously active ultrasound elements and, together with rapid post-processing, made possible by advances in computer processing power, provide near-realtime volumetric scanning. The images are obtained almost instantaneously and are of a high quality.8 Such systems provide several imaging modes, including multiplane (bi-plane and tri-plane), live 3D, 3D zoom, full-volume and 3D colour Doppler. However, although the latter two imaging modes are considered the most important, limitations in system architecture mean that the system requires the acquisition of 3D images through a number of electrocardiogram (ECG)-gated sub-volumes, followed by online reconstruction and presentation of the images. For an acquisition that is large enough for chamber visualisation and quantification, the acquisition of at least four to seven cardiac cycles, gated to the R-wave, followed by stitching of the recordings to obtain a 3D image of the entire heart is required (see Figure 1). 3D colour Doppler images are useful for the assessment of valvular regurgitation. With 3D colour Doppler mode, data acquisition is of a smaller sector of the heart, and this requires the recording of up to seven cardiac cycles. The images may be displayed as a surface rendering, orthogonal planes or multiple short-axis views, in order to facilitate viewing and analysis. RT3DE images can also be viewed from any conceivable angle, thus facilitating diagnostic and treatment planning capabilities of cardiac ultrasound.

As well as requiring time-consuming offline post-processing of data sets to produce 3DE images, early 3DE systems relied on manual assessment and quantification of cardiac function. These processes were difficult to carry out and also necessitated significant experience and training. These limitations have been addressed by the availability of software programs for analysis and quantification of 3D data sets. These software programs allow not only direct quantification of cardiac chamber volume and mass, LVEF and systolic dyssynchrony, but also assessment of regional LV wall motion at rest and during stress testing.

Another improvement in the post-processing software is the integration of border detection algorithms into the software, allowing endocardial surface detection and enabling semi-automated analysis of the LV without the need to make geometrical assumptions. Increased hard-drive capacity has made it possible to store larger data sets, while improvements in transducer technology, computing power and software have resulted in a substantial reduction in study time and improved workflow compared with earlier techniques.

Clinical Applications of the Current Realtime 3D Echocardiography Systems

The capability of current RT3DE systems to provide near-realtime volumetric images of the entire heart facilitates the assessment of cardiac chamber anatomy and function, as well as evaluation of dyssynchrony, valvular diseases and congenital abnormalities.

Assessment of the Left Ventricle

LV assessment is one of the most common and clinically important applications of echocardiography. Several clinical studies have shown the accuracy and reproducibility of RT3DE in terms of quantification of the LV outcomes to be similar to the current gold standard of MRI.9–12 RT3DE systems may also be used for the assessment of global LV function. Traditionally, the assessment of global LV function has been performed by visual interpretation to provide an estimate of LVEF. However, this subjective interpretation has limited reproducibility and is comparable to existing quantification methods derived from 2D LV volumes. By contrast, assessment and quantification of LV global function with RT3DE quantification provides a more accurate and reproducible quantification of LVEF.13,14 Such quantification has a significant impact on clinical decision-making.13,14 With regard to assessment of LV shape, a quantitative assessment by RT3DE systems provides a 3D-derived sphericity index. This index accurately reflects LV shape and may be an early and independent predictor of LV remodelling after acute myocardial infarction.15

RT3DE has also been evaluated for the assessment of other LV measures. It may be useful as part of stress echocardiography testing (dobutamine, vasodilator and even exercise). Preliminary data16 have shown that 2DE and 3DE have similar sensitivity and specificity but that the latter has a substantially reduced scanning time, which reduces the study time and improves workflow. Stress echo using RT3DE may also allow for a more accurate assessment as the volumetric images could be analysed using multiple axis views, including the standard long-axis and multiple parallel short-axis slices.17 Temporal resolution is particularly important in stress testing, and current RT3DE systems provide a much better resolution than 2DE.18 In recent years, the importance of LV dyssynchrony assessment in the selection of candidates and the prognosis (i.e. prediction of success) of cardiac resynchronisation therapy (CRT) has been realised.18,19 Increasing evidence suggests that LV intraventricular dyssynchrony can be assessed by the analysis of LV regional volumetric changes from 3DE full-volume data sets. It has been proposed that the 3DE full-volume data set may be used to obtain a systolic dyssynchrony index (SDI), which could act as a predictor of response or success with CRT.20–22 A cut-off SDI value of 6.4% has been shown to have high sensitivity and specificity (88 and 85%, respectively) and good reproducibility.

Assessment of the Right Ventricle

RT3DE has also been evaluated in the assessment of the right ventricle (RV). An accurate assessment of RV size and function is highly desired as these outcomes have important diagnostic and prognostic implications in several cardiac diseases. Historically, assessment of the RV volume has always been difficult based on the complex geometrical shape of the RV and its position in the thorax of the heart. This complex anatomy often results in failure of the geometrical assumptions made by conventional 2DE quantification methods to accurately calculate RV volumes. The currently available RT3DE devices allow for a more accurate and reproducible quantification of RV volumes. The improved results may be due to the RT3DE systems being equipped with post-processing software that can formulate a mathematical cast of the RV to calculate RV volumes and RVEFs. Improved results may also be due to the elimination of geometrical assumptions. Comparisons of 3DE and 2DE images have shown the former method to provide more accurate and reproducible results for RV assessment,23,24 and to correlate well with the results from MRI.25,26

Assessment of Valvular Structures

There has been great interest in the potential of RT3DE for the visualisation of complex structures such as the mitral valve (MV). Data sets obtained from 3DE can be cropped in order to obtain unique ‘en face’ views from both sides of the valve in realtime. Post-processing software allows visualisation of the MV anatomy in the desired plane of orientation. The availability of several imaging planes is critical for the estimation of valve areas. A single plane measurement of the vena contracta would result in a poor estimation of the effective regurgitant orifice area. The new post-processing software also allows quantification of the MV complex. Assessment of the MV by RT3DE may be helpful for understanding the anatomy and function of the cardiac valves, and initial data from 3DE have provided new insights on the mitral apparatus and the pathophysiology of mitral stenosis and regurgitation.24,27–30 Preoperative MV assessment with RT3DE may be used to provide valuable information for the planning of MV repair. Studies point to RT3DE being a feasible, accurate and highly reproducible technique in the estimation of the MV area (MVA) in patients with rheumatic mitral stenosis (RMVS).31 Furthermore, RT3DE-derived images have been demonstrated to have the best agreement with invasively determined MVA versus other echo Doppler methods that are considered the gold standards.31 3D transthoracic imaging has also been shown to be a good non-invasive comparator for pre-operative MV assessment versus the gold standard of 2D transoesophageal echocardiography.32,33 Clinically relevant supplementary information may also be provided by RT3DE, using colour Doppler flow mapping combined with 3D morphological data. This is especially relevant for patients with valvular regurgitation, where colour Doppler flow mapping can aid in the definition of jet origin and relationship to adjacent structures.24,34,35

3D Echocardiography and Congenital Heart Diseases

The ability of RT3DE to provide real-life images of the entire heart and the additional data provided by 3DE compared with 2DE open the door for the use of this technique for the imaging of congenital heart diseases.36,37 Studies in patients with congenital heart disease have shown that 3DE quantification of LV and RV volumes correlates well with MRI.38–40 RT3DE has also been shown to reliably define anatomical details of bicuspid aortic valves, tetralogy of Fallot, patent ductus arteriosus, sinus of Valsalva aneurysm, Ebstein’s anomaly, subvalvular membranes and several other complex congenital diseases.41

It is feasible that RT3DE may have an important role within the catheter laboratory as there is an increase in the use of invasive cardiology procedures, such as aortic valve replacement. In such cases, RT3DE could be used as a planimetry tool to allow cardiologists to determine as well as guide the placement of catheters based on the ability of RT3DE systems to provide accurate, almost realtime volumetric images of the heart.41,42 The benefits of clinical application of RT3DE versus 2DE are summarised in Table 1.

Limitations of the Current Realtime 3D Echocardiography Systems

While there have undoubtedly been significant advances in transducer technology and post-processing software, there are still some barriers to the widespread clinical use of RT3DE. Currently, full-volume 3D image acquisition requires recording of four or more cardiac cycles, gated to the R-wave, followed by stitching of the images to attain the full volumetric image. The use of gating and stitching of images to obtain the full-volume image can result in the appearance of stitch artefacts, especially in images obtained from patients with arrhythmias or respiratory instability. In these patients, the final volume attained from 3DE could be unusable or inaccurate. The difference in the scanning technique required for a gated verses a realtime acquisition also requires additional skill and experience, and the examiner has to rely on post-processed cropped 2D images for qualitative interpretation. Another limitation is that while image acquisition with RT3DE can reduce scanning time versus conventional 2DE techniques, the spatial and temporal resolution of the final image still needs to be improved to rival that of 2DE, while ensuring that the scanning time is still short. There is still a significant need for expertise and training in the manipulation of data sets as post-processing software can only semi-automatically quantify chamber volumes. The importance of and need for training was highlighted by a study where the discrepancy in the estimation of volumes by 3DE versus MRI could be overcome if 3DE were carried out by experienced physicians.43

Recent Developments in 3D Echocardiography

During the last decade there has been a continuous evolution in 3DE technology, with progress seen every year. The most recent innovation has been a move away from the traditional serial line-by-line acquisition to using simultaneous multiple beams, resulting in the acquisition of non-stitched, realtime, full-volume 3D images of the heart in a single heart cycle.

Rapid acquisition of large volumes (90ºx90º) at high volume rates (>20 volumes/second) allows acquisition of the entire heart instantaneously in true realtime in one cardiac cycle, without the need for ECG gating and stitching of multiple cardiac cycles (see Figure 2). This speeds image acquisition, removes the problem of stitch artefacts and improves feasibility, image quality and accuracy in a broader range of patients, including those with irregular cardiac cycles (e.g. those with heart failure or arrhythmia) or with breathing difficulties. Furthermore, as the image of the entire heart is displayed continuously in realtime during the image scanning, the orientation within and optimisation of the volume is more intuitive and easier to learn than with the ECG-gated methods.

Other innovations, such as knowledge-based workflow and pattern recognition tools, are now available that allow fully automated extraction and quantification of all of the information needed from a complete study. The use of learned patterned recognition algorithms based on expert databases of real clinical cases in these tools enables the recognition of anatomical patterns as well as fully automatic measurements. Fully automatic data extraction, measurement and analysis will further improve workflow by reducing examination time and intra- and inter-operator variation. Morphological assessment and 3D stress echocardiographic testing may especially benefit from the advanced post-processing software as it allows fast and easy manual rotation throughout the complete 3D data set and rendering of standard cut planes for wall-motion analysis. Doppler is a critical aspect for diagnosis of flow through leaking valves and shunts, and the ability of the new RT3DE systems to depict flow information in 3D with colour Doppler is a major step forward for 3DE (see Figure 3). Such imaging capability offers a complete approach for the evaluation of disease, particularly the assessment of valvular problems, allowing a more exact and precise analysis of valve pathologies.

The combination of improved acquisition via the instantaneous full-volume imaging and knowledge-based workflow have the potential to overcome the current limitations that prevent RT3DE being adopted into routine clinical practice. In the future, rather than being added to the 2DE exam, RT3DE will be integrated into cardiac imaging, possibly even replacing part of the 2DE as this could reduce the examination time (see Figure 4).

Conclusions

There have been significant advances in RT3DE technology, and post-processing and analysis have generated sufficient evidence to support the adoption of RT3DE for routine clinical use. The current RT3DE systems allow fast acquisition of full-volume images of the heart. Semi-automated post-processing software allows rapid quantification and assessment of chamber volumes and functions. Furthermore, RT3DE has been shown to be comparable to the gold standard of 3D cardiac imaging, MRI, in the assessment of cardiac volumes and function. Nevertheless, there are still limitations associated with the current RT3DE systems. Full-volume acquisition necessitates the imaging of at least four cardiac cycles, gated to the R-wave, followed by stitching of the images to acquire the full volume. The presence of stitch artefacts and need for prolonged breath-holding and recording of multiple cardiac cycles to acquire the images may result in poorer image quality and inaccurate quantification and assessment of cardiac outcomes. The technique may be particularly unsuitable for patients with dyspnoea or irregular cardiac cycles. Since the post-processing is only semi-automated, there is often a need for expertise and training in the use of the software.

As 3DE technologies continue to advance, RT3DE will be integrated into multimodal imaging workflows. Instantaneous acquisition of the full volume of the heart in one cardiac cycle eliminates the need for prolonged breath-holding and stitched acquisition. Post-processing carried out by a knowledge-based workflow and fully automated quantification and pattern recognition software will also have a positive impact on the current workflow. It is anticipated that the continuing advances in technology will improve exam time, workflow and image quality, as well as the accuracy, speed and simplicity of quantification and assessment of cardiac outcomes, and will help in the integration of 3DE into clinical routine.

References
  1. Lang RM, Bierig M, Devereux RB, et al., Recommendations for chamber quantification, Eur J Echocardiogr, 2006;7:79–108.
    Crossref | PubMed
  2. Gopal AS, Keller AM, Rigling R, et al., Left ventricular volume and endocardial surface area by threedimensional echocardiography: comparison with twodimensional echocardiography and nuclear magnetic resonance imaging in normal subjects, J Am Coll Cardiol, 1993;22:258–70.
    Crossref | PubMed
  3. Gopal AS, Schnellbaecher MJ, Shen Z, et al., Freehand three-dimensional echocardiography for determination of left ventricular volume and mass in patients with abnormal ventricles: comparison with magnetic resonance imaging, J Am Soc Echocardiogr, 1997;10:853–61.
    Crossref | PubMed
  4. Dekker DL, Piziali RL, Dong E, Jr., A system for ultrasonically imaging the human heart in three dimensions, Comput Biomed Res, 1974;7:544–53.
    Crossref | PubMed
  5. Gordon EP, Schnittger I, Fitzgerald PJ, et al., Reproducibility of left ventricular volumes by two-dimensional echocardiography, J Am Coll Cardiol, 1983;2:506–13.
    Crossref | PubMed
  6. von Ramm OT, Smith SW, Real time volumetric ultrasound imaging system, J Digit Imaging, 1990;3:261–6.
    Crossref | PubMed
  7. Sheikh K, Smith SW, von Ramm O, et al., Real-time, threedimensional echocardiography: feasibility and initial use, Echocardiography, 1991;8:119–25.
    Crossref | PubMed
  8. Wang XF, Deng YB, Nanda NC, et al., Live threedimensional echocardiography: imaging principles and clinical application, Echocardiography, 2003;20:593–604.
    Crossref | PubMed
  9. Arai K, Hozumi T, Matsumura Y, et al., Accuracy of measurement of left ventricular volume and ejection fraction by new real-time three-dimensional echocardiography in patients with wall motion abnormalities secondary to myocardial infarction, Am J Cardiol, 2004;94:552–8.
    Crossref | PubMed
  10. Jenkins C, Bricknell K, Hanekom L, et al., Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography, J Am Coll Cardiol, 2004;44:878–6.
    Crossref | PubMed
  11. Kuhl HP, Schreckenberg M, Rulands D, et al., Highresolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging, J Am Coll Cardiol, 2004;43:2083–90.
    Crossref | PubMed
  12. Gutierrez-Chico JL, Zamorano JL, Perez de Isla L, et al., Comparison of left ventricular volumes and ejection fractions measured by three-dimensional echocardiography versus by two-dimensional echocardiography and cardiac magnetic resonance in patients with various cardiomyopathies, Am J Cardiol, 2005;95:809–13.
    Crossref | PubMed
  13. Caiani EG, Corsi C, Sugeng L, et al., Improved quantification of left ventricular mass based on endocardial and epicardial surface detection with real time three dimensional echocardiography, Heart, 2006;92:213–19.
    Crossref | PubMed
  14. Hare JL, Jenkins C, Nakatani S, et al., Feasibility and clinical decision-making with 3D echocardiography in routine practice, Heart, 2008;94:440–45.
    Crossref | PubMed
  15. Mannaerts HF, van der Heide JA, Kamp O, et al., Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography, Eur Heart J, 2004;25:680–87.
    Crossref | PubMed
  16. Matsumura Y, Hozumi T, Arai K, et al., Non-invasive assessment of myocardial ischaemia using new real-time three-dimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods, Eur Heart J, 2005;26:1625–32.
    Crossref | PubMed
  17. Franke A, Real-time three-dimensional echocardiography in stress testing: bi- and triplane imaging for enhanced image acquisition, Cardiol Clin, 2007;25:261–5.
    Crossref | PubMed
  18. Takeuchi M, Otani S, Weinert L, et al., Comparison of contrast-enhanced real-time live 3-dimensional dobutamine stress echocardiography with contrast 2-dimensional echocardiography for detecting stressinduced wall-motion abnormalities, J Am Soc Echocardiogr, 2006;19:294–9.
    Crossref | PubMed
  19. Bax JJ, Abraham T, Barold SS, et al., Cardiac resynchronization therapy: Part 1—issues before device implantation, J Am Coll Cardiol, 2005;46:2153–67.
    Crossref | PubMed
  20. Kapetanakis S, Kearney MT, Siva A, et al., Real-time threedimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony, Circulation, 2005;112:992–1000.
    Crossref | PubMed
  21. Marsan NA, Bleeker GB, Ypenburg C, et al., Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy, J Cardiovasc Electrophysiol, 2008;19:392–9.
    Crossref | PubMed
  22. Marsan NA, Henneman MM, Chen J, et al., Real-time three-dimensional echocardiography as a novel approach to quantify left ventricular dyssynchrony: a comparison study with phase analysis of gated myocardial perfusion single photon emission computed tomography, J Am Soc Echocardiogr, 2008;21:801–7.
    Crossref | PubMed
  23. Kjaergaard J, Petersen CL, Kjaer A, et al., Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI, Eur J Echocardiogr, 2006;7:430–38.
    Crossref | PubMed
  24. Sugeng L, Coon P, Weinert L, et al., Use of real-time 3- dimensional transthoracic echocardiography in the evaluation of mitral valve disease, J Am Soc Echocardiogr, 2006;19:413–21.
    Crossref | PubMed
  25. Jenkins C, Chan J, Bricknell K, et al., Reproducibility of right ventricular volumes and ejection fraction using realtime three-dimensional echocardiography: comparison with cardiac MRI, Chest, 2007;131:1844–51.
    Crossref | PubMed
  26. Prakasa KR, Dalal D, Wang J, et al., Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/ cardiomyopathy, Am J Cardiol, 2006;97:703–9.
    Crossref | PubMed
  27. Levine RA, Handschumacher MD, Sanfilippo AJ, et al., Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse, Circulation, 1989;80:589–98.
    Crossref | PubMed
  28. Otsuji Y, Handschumacher MD, Schwammenthal E, et al., Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry, Circulation, 1997;96:1999–2008.
    Crossref | PubMed
  29. Watanabe N, Ogasawara Y, Yamaura Y, et al., Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography, J Am Coll Cardiol, 2005;45:763–9.
    Crossref | PubMed
  30. Liel-Cohen N, Guerrero JL, Otsuji Y, et al., Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from 3-dimensional echocardiography, Circulation, 2000;101: 2756–63.
    Crossref | PubMed
  31. Zamorano J, Cordeiro P, Sugeng L, et al., Real-time threedimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach, J Am Coll Cardiol, 2004;43:2091–6.
    Crossref | PubMed
  32. Gutierrez-Chico JL, Zamorano Gomez JL, Rodrigo-Lopez JL, et al., Accuracy of real-time 3-dimensional echocardiography in the assessment of mitral prolapse. Is transesophageal echocardiography still mandatory?, Am Heart J, 2008;155:694–8.
    Crossref | PubMed
  33. Agricola E, Oppizzi M, Pisani M, et al., Accuracy of realtime 3D echocardiography in the evaluation of functional anatomy of mitral regurgitation, Int J Cardiol, 2008;127: 342–9.
    Crossref | PubMed
  34. De Simone R, Glombitza G, Vahl CF, et al., Threedimensional color Doppler: a new approach for quantitative assessment of mitral regurgitant jets, J Am Soc Echocardiogr, 1999;12:173–85.
    Crossref | PubMed
  35. Breburda CS, Griffin BP, Pu M, et al., Three-dimensional echocardiographic planimetry of maximal regurgitant orifice area in myxomatous mitral regurgitation: intraoperative comparison with proximal flow convergence, J Am Coll Cardiol, 1998;32:432–7.
    Crossref | PubMed
  36. Chan KL, Liu X, Ascah KJ, et al., Comparison of real-time 3-dimensional echocardiography with conventional 2-dimensional echocardiography in the assessment of structural heart disease, J Am Soc Echocardiogr, 2004;17: 976–80.
    Crossref | PubMed
  37. Salustri A, Spitaels S, McGhie J, et al., Transthoracic threedimensional echocardiography in adult patients with congenital heart disease, J Am Coll Cardiol, 1995;26:759–67.
    Crossref | PubMed
  38. Niemann PS, Pinho L, Balbach T, et al., Anatomically oriented right ventricular volume measurements with dynamic three-dimensional echocardiography validated by 3-Tesla magnetic resonance imaging, J Am Coll Cardiol, 2007;50:1668–76.
    Crossref | PubMed
  39. Papavassiliou DP, Parks WJ, Hopkins KL, et al., Threedimensional echocardiographic measurement of right ventricular volume in children with congenital heart disease validated by magnetic resonance imaging, J Am Soc Echocardiogr, 1998;11:770–77.
    Crossref | PubMed
  40. van den Bosch AE, Robbers-Visser D, Krenning BJ, et al., Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease, J Am Soc Echocardiogr, 2006;19:1–6.
    Crossref | PubMed
  41. Del Pasqua A, Sanders SP, de Zorzi A, et al., Impact of three-dimensional echocardiography in complex congenital heart defect cases: the surgical view, Pediatr Cardiol, 2009;30:293–300.
    Crossref | PubMed
  42. Marsan NA, Tops LF, Nihoyannopoulos P, et al., Real-time three dimensional echocardiography: current and future clinical applications, Heart, 2009;95:1881–90.
    Crossref | PubMed
  43. Mor-Avi V, Jenkins C, Kuhl HP, et al., Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error, JACC Cardiovasc Imaging, 2008;1:413–23.
    Crossref | PubMed